SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors weigh strong demand for the Keytruda and Winrevair franchises against the company's urgent need to secure new oncology assets ahead of the Keytruda patent cliff. The community is actively discussing potential M&A targets that could fill the revenue void, with speculative focus intensifying around the valuation of biotech platform developers.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining traction as community members highlight its role in the oracle and real-world asset space, driven by enthusiasm over institutional partnerships and the platform's transition to a paid service model. Investors are actively debating the long-term potential of its data delivery infrastructure, frequently comparing it to established projects like Chainlink while weighing the risks associated with token supply mechanics.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as the market prices in the massive potential for its pancreatic cancer drug, Daraxonrasib, following transformative Phase 3 survival data. The community is actively discussing the stock's role as a primary acquisition target for major pharmaceutical firms looking to mitigate patent cliffs, with extensive debate surrounding its valuation compared to peers and the ongoing bidding interest following unsuccessful buyout attempts.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is currently in focus as investors weigh the stock's long-term compounding potential against recent regulatory headwinds and market rotation into AI-linked assets. While some market participants are voicing concerns about potential legislative caps on credit card interest rates and the emergence of new AI-driven payment competitors, a vocal segment of the community views the recent price pullback as an attractive entry point to gain exposure to a high-quality global network.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is capturing investor attention as the market evaluates the stock's stability and yield potential amid ongoing dividend sustainability debates. The community is actively discussing the impact of high debt levels, competitive pricing pressures in the Canadian telecom sector, and the company's long-term pivot toward AI infrastructure and digital health.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2024 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is experiencing significant market interest following reports that Apollo-backed Legendary Entertainment is exploring a potential takeover. Investors are actively debating whether this signals a long-awaited acquisition and what a reasonable per-share valuation would be as they speculate on further consolidation in the media sector.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trending as investors focus on the commercial launch of its FDA-approved gene therapy, ZEVASKYN, and the expansion of its network of Qualified Treatment Centers. Community discussions are heavily centered on the company's strong cash position, the strategic importance of permanent J-code reimbursement, and anticipation for upcoming financial updates as the company moves toward scalable revenue growth.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as the community debates its long-term potential following recent partnerships with the ASK Group and integration efforts within the UAE market. Investors are actively discussing the project's utility in real-world asset tokenization and cross-border payments, balancing high expectations for infrastructure growth against frustration over volatile price action.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering investor attention due to its central role in powering real-world asset (RWA) tokenization and institutional financial infrastructure. Community discussion is heavily focused on its long-term utility and partnerships, with many users employing dollar-cost averaging strategies while debating whether current market sentiment undervalues the project's foundational role in the evolving digital economy.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is experiencing significant market volatility as investors weigh a strong earnings beat and raised guidance against concerns over mounting fuel costs. While the community is actively debating the stock's potential for further upside, sentiment remains cautious due to ongoing macroeconomic uncertainties and sector-wide fuel pricing pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nuveen Municipal Credit Opportunities Fund is a closed end investment fund. Its investment objective is to provide a level of current income exempt from regular U.S. federal income tax. The fund was founded on April 18, 2019 and is headquartered in Chicago, IL.

Nuveen Municipal Credit Opportunities Fund

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$10.81
Prev Close	$10.85
Open	$10.83
Dividend Yield	7.52%
50-Day Moving Average	$10.77
Beta	0.26
Avg. Volume	148,084.84
PE Ratio	22.24

52-Week High	$11.00
52-Week Low	$9.95
Market Capitalization	$598.76M
EPS (Annual)	$0.0206
Price to Book	1.02
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

NMCONuveen Municipal Credit Opportunities Fund

Latest NMCO News